Pharma dealmaking for drugs invented in China is putting pressure on U.S. biotechs to compete harder, according to investors ...
Artificial intelligence (AI) is driving the highest gains in the market, and several of the largest companies in the world ...
This month, pharma companies have announced plans to increase the prices of more than 250 branded drugs in the US.
It maintains a diverse revenue base, a developing research pipeline, and exceptional cash flow generation that together create a wide economic moat. J&J holds a leadership role in diverse healthcare ...
The cancer therapeutics market is set to exceed $400 billion. Read why five pharmaceutical companies offer attractive ...
Investing News Network on MSN4d
Pharma Market Forecast: Top Trends for Pharma in 2025The pharmaceutical industry is poised for a dynamic year in 2025. A confluence of positive trends suggests a brighter outlook ...
Bayer expects its pharmaceutical business to return to growth in 2027 as the launch new therapies is expected to offset ...
From established players to up-and-coming firms, Canada's pharmaceutical company landscape is diverse and dynamic. Canadian ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback